Bioreactors for manufacture of human platelets. Blood cell transfusion is a critical part of medicine that is supported by volunteer donors. Unfortunately, the demand for blood cells for transfusion far outstrips supply and therefore new strategies are required for manufacture of blood cells. This project will lead to the development of technology for manufacture of human platelets from stem cells. The systems devised will be applicable to a broad range of other blood cell types.
Engineering nanomaterial interactions with the cell surface. This Fellowship aims to advance understanding of the endothelial cell surface, a key tissue barrier, and its interactions with nanomaterials. Enabled by cross-disciplinary collaboration, it expects to develop knowledge in matrix biology of the cell surface and materials as well as new methods to analyse their interactions. This is expected to unravel causal relationships between nanomaterial features and interactions at the cell surfac ....Engineering nanomaterial interactions with the cell surface. This Fellowship aims to advance understanding of the endothelial cell surface, a key tissue barrier, and its interactions with nanomaterials. Enabled by cross-disciplinary collaboration, it expects to develop knowledge in matrix biology of the cell surface and materials as well as new methods to analyse their interactions. This is expected to unravel causal relationships between nanomaterial features and interactions at the cell surface which will be integrated to engineer optimised materials. This will address the current and critical challenges of nanomaterial technologies in the efficient and targeted interactions with cells with long-term benefits for the consumer, biotechnology and healthcare sectors.Read moreRead less
Nanoparticle formulations for DNA-targeted radiotherapy and imaging: combinations with chromatin-modifying compounds. This project will develop a new approach for treating and imaging cancer using nanoparticles which target specific cells for cancer therapy and diagnostic imaging. The nanoparticles will be combined with compounds that alter the architecture of DNA to make therapy more effective and to improve the safety of imaging.
Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted del ....Platinum drugs containing core-shell nanoparticles. Many drugs such as cancer drugs contain metal ions. While the therapeutic benefits of metal containing drugs are highly promising, their administration is often accompanied by substantial side effects. Encapsulation of these drugs into nano-sized core-shell particles will prolong the circulation of the drug and therefore reduce the amount of repeated administrations. In addition, the shape and nature of the particle will enable the targeted delivery of these drug loaded nanocarriers to the tumor while healthy tissue remains unaffected. Read moreRead less
Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D prin ....Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D printing of living cells and commercially viable reprogramming materials. The project expects to contribute fundamental knowledge in materials and biomedical sciences, while providing tools that will benefit commercial ventures in cell and tissue manufacturing.Read moreRead less
Programming physical and biological cues to promote vessel growth . This project aims to engineer new hydrogel-based biomaterials that allow spatio-temporal modulation of physical and biological cues to direct blood vessels growth, as well as compatible with advanced bioprinting platforms. It will generate new knowledge in biomaterials, biofabrication and advanced material processing. Expected outcomes include new knowledge in biomaterial-vascular interaction, novel vascular bioinks, cross-disci ....Programming physical and biological cues to promote vessel growth . This project aims to engineer new hydrogel-based biomaterials that allow spatio-temporal modulation of physical and biological cues to direct blood vessels growth, as well as compatible with advanced bioprinting platforms. It will generate new knowledge in biomaterials, biofabrication and advanced material processing. Expected outcomes include new knowledge in biomaterial-vascular interaction, novel vascular bioinks, cross-disciplinary, international collaboration and research training. This project will provide significant benefit to Australia's scholarly output and reputation, as well as long term benefits to biomedical, veterinary and cosmetic through new materials and cutting-edge manufacturing platforms. Read moreRead less
Engineering biomaterials that actively promote blood vessel growth. This project aims to improve understanding of the effect of biomaterials on vascular growth & to develop new biomimetic materials using natural polymers silk & gelatin. It expects to generate new knowledge in biomaterials, matrix biology & advanced material processing. Expected outcomes include new knowledge & technological advances in biomaterial-driven vascular growth, porous material manufacture, & proteoglycan-mediated grow ....Engineering biomaterials that actively promote blood vessel growth. This project aims to improve understanding of the effect of biomaterials on vascular growth & to develop new biomimetic materials using natural polymers silk & gelatin. It expects to generate new knowledge in biomaterials, matrix biology & advanced material processing. Expected outcomes include new knowledge & technological advances in biomaterial-driven vascular growth, porous material manufacture, & proteoglycan-mediated growth factor signalling, as well as cross-disciplinary, international collaboration & research training. This should provide significant benefit to Australia’s scholarly output & reputation & long term benefits to biomedical, veterinary, cosmetic, & food industries through new materials & processing technologies. Read moreRead less